Notably, Singh and colleagues (38) recently reported that melanoma cells are reliant on DUSP1 and DUSP8 expression for proliferation and that DUSP1 protein expression is reduced in MAPKi-sensitive and -resistant melanoma cells treated with BRAFi, consistent with the data reported here. This evidence concerns the gene DUSP8 and melanoma.